Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk PMV Pharmaceuticals, Inc. per 2025 Jun 30 adalah -90.90 MM.
- Nilai net income untuk PMV Pharmaceuticals, Inc. per 2025 Jun 30 adalah -80.87 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -90.90 | -80.87 | |
2025-03-31 | -88.79 | -60.88 | |
2024-12-31 | -84.85 | -58.71 | |
2024-09-30 | -79.18 | -51.47 | |
2024-06-30 | -76.92 | -48.88 | |
2024-03-31 | -76.27 | -65.10 | |
2023-12-31 | -80.13 | -68.96 | |
2023-09-30 | -82.39 | -72.55 | |
2023-06-30 | -82.14 | -74.14 | |
2023-03-31 | -79.90 | -74.01 | |
2022-12-31 | -77.04 | -73.32 | |
2022-09-30 | -74.35 | -72.33 | |
2022-06-30 | -70.07 | -69.11 | |
2022-03-31 | -65.24 | -64.68 | |
2021-12-31 | -58.29 | -57.85 | |
2021-09-30 | -50.32 | -49.94 | |
2021-06-30 | -43.93 | -43.70 | |
2021-03-31 | -38.96 | -38.79 | |
2020-12-31 | -34.94 | -34.44 | |
2020-09-30 | -31.80 | -31.03 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -1.56.
- laba per saham yang terdilusi untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -1.56.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -1.56 | -1.56 |
2025-03-31 | -1.18 | -1.18 |
2024-12-31 | -1.14 | |
2024-09-30 | -1.00 | -1.00 |
2024-06-30 | -0.96 | -0.96 |
2024-03-31 | -1.32 | -1.32 |
2023-12-31 | -1.44 | |
2023-09-30 | -1.56 | -1.56 |
2023-06-30 | -1.62 | -1.62 |
2023-03-31 | -1.62 | -1.62 |
2022-12-31 | -1.61 | |
2022-09-30 | -1.59 | -1.59 |
2022-06-30 | -1.52 | -1.52 |
2022-03-31 | -1.43 | -1.43 |
2021-12-31 | -1.28 | |
2021-09-30 | -1.11 | -1.11 |
2021-06-30 | -1.24 | -1.24 |
2021-03-31 | -1.56 | -1.56 |
2020-12-31 | -2.40 | |
2020-09-30 | -8.18 | -8.18 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk PMV Pharmaceuticals, Inc. per 2025 Jun 30 adalah -70.07 MM.
- Nilai cash from investing activities untuk PMV Pharmaceuticals, Inc. per 2025 Jun 30 adalah 64.56 MM.
- Nilai kas dari aktivitas pendanaan untuk PMV Pharmaceuticals, Inc. per 2025 Jun 30 adalah 0.28 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -70.07 | 64.56 | 0.28 |
2025-03-31 | -53.36 | 55.90 | 0.32 |
2024-12-31 | -51.28 | 53.35 | 0.31 |
2024-09-30 | -46.71 | 43.02 | 0.43 |
2024-06-30 | -45.53 | -7.74 | 33.58 |
2024-03-31 | -56.83 | -74.02 | 35.56 |
2023-12-31 | -55.66 | -50.55 | 35.58 |
2023-09-30 | -58.90 | -24.73 | 35.84 |
2023-06-30 | -60.00 | 38.42 | 2.70 |
2023-03-31 | -60.77 | 87.10 | 0.84 |
2022-12-31 | -63.76 | -1.37 | 0.96 |
2022-09-30 | -60.46 | -17.03 | 0.70 |
2022-06-30 | -56.10 | -47.24 | 1.01 |
2022-03-31 | -51.66 | -42.51 | 1.99 |
2021-12-31 | -46.57 | -143.58 | 2.02 |
2021-09-30 | -44.85 | -151.20 | 0.37 |
2021-06-30 | -39.85 | -142.47 | 294.51 |
2021-03-31 | -37.51 | -105.60 | 293.13 |
2020-12-31 | -32.74 | 27.91 | 292.97 |
2020-09-30 | -27.55 | 9.41 | 356.04 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah 0.34.
- p/tbv untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah 0.34.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.34 | 0.34 | |
2025-03-31 | 0.33 | 0.33 | |
2024-12-31 | 0.39 | 0.39 | |
2024-09-30 | -1.58 | 0.36 | 0.36 |
2024-06-30 | -1.31 | 0.40 | 0.40 |
2024-03-31 | 0.38 | 0.38 | |
2023-12-31 | -2.19 | 0.67 | 0.67 |
2023-09-30 | -4.01 | 1.36 | 1.36 |
2023-06-30 | -3.70 | 1.19 | 1.19 |
2023-03-31 | -2.97 | 0.89 | |
2022-12-31 | 1.52 | 1.52 | |
2022-09-30 | 1.96 | 1.96 | |
2022-06-30 | -10.06 | 2.23 | 2.23 |
2022-03-31 | -16.34 | 3.06 | 3.06 |
2021-12-31 | -21.01 | 3.23 | 3.23 |
2021-09-30 | -30.89 | 4.00 | 4.00 |
2021-06-30 | |||
2021-03-31 | -18.22 | 2.03 | 2.03 |
2020-12-31 | -20.48 | 1.96 | 1.96 |
2020-09-30 | -22.72 | 1.91 | 1.91 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -21.22.
- EBIT (3 tahun) / EV untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -19.51.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -21.22 | -19.51 |
2025-03-31 | -4.46 | -4.25 |
2024-12-31 | -2.39 | -2.47 |
2024-09-30 | -2.26 | -2.43 |
2024-06-30 | -1.72 | -1.80 |
2024-03-31 | -1.46 | -1.41 |
2023-12-31 | -0.68 | -0.61 |
2023-09-30 | -0.32 | -0.27 |
2023-06-30 | -0.56 | -0.47 |
2023-03-31 | -0.67 | -0.54 |
2022-12-31 | -0.24 | -0.17 |
2022-09-30 | -0.15 | -0.11 |
2022-06-30 | -0.12 | -0.09 |
2022-03-31 | -0.07 | -0.05 |
2021-12-31 | -0.06 | -0.04 |
2021-09-30 | -0.04 | -0.02 |
2021-06-30 | ||
2021-03-31 | -0.08 | -0.06 |
2020-12-31 | -0.07 | -0.05 |
2020-09-30 | -0.06 | -0.02 |
Efektivitas Manajemen
- roa untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.26.
- roe untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.28.
- roic untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.38.
- croic untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah 0.02.
- ocroic untuk PMV Pharmaceuticals, Inc. pada 2025 Jun 30 adalah -0.33.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.26 | -0.28 | -0.38 | 0.02 | -0.33 |
2025-03-31 | -0.25 | -0.28 | -0.33 | 0.01 | -0.29 |
2024-12-31 | -0.20 | -0.23 | -0.24 | -0.02 | -0.22 |
2024-09-30 | -0.19 | -0.21 | -0.22 | -0.09 | -0.20 |
2024-06-30 | -0.26 | -0.28 | -0.29 | -0.42 | -0.25 |
2024-03-31 | -0.26 | -0.28 | -0.29 | -0.30 | -0.23 |
2023-12-31 | -0.25 | -0.28 | -0.29 | -0.19 | -0.24 |
2023-09-30 | -0.25 | -0.27 | -0.32 | -0.08 | -0.26 |
2023-06-30 | -0.25 | -0.27 | -0.32 | -0.08 | -0.26 |
2023-03-31 | -0.23 | -0.25 | -0.30 | 0.11 | -0.25 |
2022-12-31 | -0.21 | -0.22 | -0.26 | -0.28 | -0.22 |
2022-09-30 | -0.20 | -0.21 | -0.26 | -0.28 | -0.22 |
2022-06-30 | -0.18 | -0.19 | -0.24 | -0.35 | -0.19 |
2022-03-31 | -0.16 | -0.17 | -0.21 | -0.30 | -0.17 |
2021-12-31 | -0.14 | -0.14 | -0.18 | -0.59 | -0.13 |
2021-09-30 | -0.13 | -0.12 | -0.15 | -0.58 | -0.11 |
2021-06-30 | -0.49 | -0.52 | -0.13 | 0.32 | -0.11 |
2021-03-31 | -0.38 | -0.39 | -0.11 | 0.43 | -0.11 |
2020-12-31 | -0.33 | -0.35 | -0.10 | 0.80 | -0.09 |
2020-09-30 | -0.51 | -0.08 | 0.92 | -0.07 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1699382 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |